Hakutulokset - Sarah Doffman

  • Näytetään 1 - 5 yhteensä 5 tuloksesta
Tarkenna hakua
  1. 1
    The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

    The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Tekijä Gareth Reynold Davies, Athol U. Wells, Sarah Doffman, Shobu Watanabe, Robert Wilson

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR

    Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR Tekijä Lisa J. Griffiths, Martin Anyim, Sarah Doffman, Mark Wilks, Michael Millar, Samir Agrawal

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease

    Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease Tekijä HJ Milburn, Neil Ashman, Peter Davies, Sarah Doffman, F. Drobniewski, Saye Khoo, P Ormerod, Marlies Ostermann, Catherine Snelson

    Julkaistu 2010
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients

    Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients Tekijä Jonathan Lambourne, Dan Agranoff, Raoul Herbrecht, Peter F. Troke, Aby Buchbinder, Fenella Willis, Valérie Letscher‐Bru, Samir Agrawal, Sarah Doffman, Elizabeth M. Johnson, P. Lewis White, Rosemary A. Barnes, George E. Griffin, Jodi A. Lindsay, Thomas S. Harrison

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4

    A phase 2a trial of the IL-33 mAb tozorakimab in patients with COPD: FRONTIER-4 Tekijä Dave Singh, Patricia Guller, Fred Reid, Sarah Doffman, Ulla Seppälä, Ioannis Psallidas, Rachel Moate, Rebecca Smith, Joanna Kiraga, Eulalia Jiménez, Dennis E. Brooks, Aoife Kelly, Lars H. Nordenmark, Muhammad Waqas Sadiq, Luis Mateos Caballero, Chris Kell, Maria G. Belvisi, Hitesh Pandya

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: